Related Experiment Video
Updated: Jan 31, 2026

A New Approach that Eliminates Handling for Studying Aggression and the "Loser" Effect in Drosophila melanogaster
Published on: December 30, 2015
ALK testing methods: is there a winner or loser?
Yuka Kozuma1,2, Gouji Toyokawa2, Takashi Seto1
1a Department of Thoracic Oncology , National Kyushu Cancer Center , Fukuoka , Japan.
Introduction:
Anaplastic lymphoma kinase (ALK) is one of the most attractive molecular targets for the treatment of patients with non-small-cell lung cancer. Treatment with ALK inhibitors is recognized as the standard-of-care for patients with ALK gene rearrangements, but it is important to appropriately select patients who will benefit from such treatment. Areas covered: In this article, we review the evidence regarding ALK testing. Immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), and reverse transcription polymerase chain reaction (RT-PCR) are the representative methods for detecting ALK gene fusions. Among these diagnostic modalities, IHC in particular exhibits high sensitivity and specificity for the detection of ALK fusions when appropriately applied and interpreted. Expert commentary: Discrepancies have been reported between the results of IHC and FISH. However, it was revealed that patients with IHC-positivity and FISH-negativity may respond to alectinib, indicating that IHC can be used as a stand-alone method from a clinical standpoint for the identification of patients eligible for treatment with ALK inhibitors. In addition, differences between ALK variants have been reported to affect the prognosis and efficacy of ALK inhibitor-based treatments, and RT-PCR will likely increase in importance as a complementary tool.
Insights
Anaplastic lymphoma kinase (ALK) testing is crucial for non-small-cell lung cancer treatment. Immunohistochemistry (IHC) shows high accuracy for identifying patients who will benefit from ALK inhibitors.
Area of Science:
- Oncology
- Molecular Diagnostics
- Genetics
Background:
- Anaplastic lymphoma kinase (ALK) is a key molecular target in non-small-cell lung cancer (NSCLC).
- ALK inhibitors are standard care for patients with ALK gene rearrangements, necessitating accurate patient selection.
- Effective patient stratification is vital for optimizing ALK inhibitor therapy outcomes.
Purpose of the Study:
- To review current evidence on Anaplastic lymphoma kinase (ALK) testing methodologies for NSCLC.
- To evaluate the diagnostic performance and clinical utility of different ALK detection methods.
- To provide insights into patient selection for ALK inhibitor treatment.
Main Methods:
- Review of evidence on ALK testing in NSCLC.
- Comparison of Immunohistochemistry (IHC), Fluorescence In Situ Hybridization (FISH), and Reverse Transcription Polymerase Chain Reaction (RT-PCR).
- Analysis of diagnostic accuracy, sensitivity, and specificity of IHC for ALK fusion detection.
Main Results:
- Immunohistochemistry (IHC) demonstrates high sensitivity and specificity for detecting ALK fusions when properly performed.
- Discrepancies between IHC and FISH exist, but IHC-positive/FISH-negative patients may still respond to alectinib.
- ALK variants can influence prognosis and treatment efficacy, highlighting the potential role of RT-PCR.
Conclusions:
- Immunohistochemistry (IHC) can serve as a standalone method for identifying patients eligible for ALK inhibitor therapy.
- While FISH is a standard, IHC's performance supports its clinical use in ALK testing.
- Reverse Transcription Polymerase Chain Reaction (RT-PCR) may become important for characterizing ALK variants and complementing other tests.
Related Concept Videos
Testes: Histology
The spermatogenic cells, responsible for producing sperm, are...
Complementation Tests
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Significance Testing: Overview
Testes: Gross Anatomy
Each testis is surrounded by the tunica albuginea, a dense connective tissue layer that provides structural support and protection. This layer is covered by an outer serous membrane called the tunica vaginalis, which helps reduce friction...
Testing Water Quality
Types of Hypothesis Testing
When the null and alternative hypotheses are stated, it is observed that the null hypothesis is a neutral statement against which the alternative hypothesis is tested. The alternative hypothesis is a claim that instead has a certain direction. If the null hypothesis claims that p = 0.5, the alternative hypothesis would be an opposing statement to this and can be put either p > 0.5, p < 0.5, or p...

